3 documents found, page 1 of 1
Clinical Standards for Diagnosis, Treatment and Prevention of Post-COVID-19 Lun...
Visca, D; Centis, R; Pontali, E; Zampogna, E; Russell, AM; Migliori, GB; Andrejak, C; Aro, M; Bayram, H; Berkani, K; Bruchfeld, J; Chakaya, JMBACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the...
Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both?
Bousquet, J; Dinh-Xuan, AT; Similowski, T; Malva, J; Ankri, J; Barbagallo, M; Fabbri, L; Humbert, M; Mercier, J; Robalo-Cordeiro, C; Rodriguez-Manas, L
ARIA 2016: Care pathways implementing emerging technologies for predictive medi...
Bousquet, J; Hellings, PW; Agache, I; Bedbrook, A; Bachert, C; Bergmann, KC; Bewick, M; Bindslev-Jensen, C; Bosnic-Anticevitch, S; Bucca, C; Caimmi, DPThe Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and im...